Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin H Mullish

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
The American Journal of Gastroenterology|February 8, 2019
Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical TrialJessica R Allegretti, Zain Kassam, Madeline Carrellas, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2019
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volumeRobin D Abeles, Benjamin H Mullish, Roberta Forlano, et al.
Gastroenterology|July 21, 2018
Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal MicrobiotaJulie A K McDonald, Benjamin H Mullish, Alexandros Pechlivanis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2019
High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver DiseaseRoberta Forlano, Benjamin H Mullish, Nikolaos Giannakeas, et al.
Nutrients|December 23, 2022
Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in HumansJessica-Miranda Bustamante, Tyson Dawson, Caitlin Loeffler, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2021
Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel diseaseShiva T Radhakrishnan, James L Alexander, Benjamin H Mullish, et al.
Gut Microbes|March 25, 2021
Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?Benjamin H Mullish, Julian R Marchesi, Julie A K McDonald, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2025
Clostridioides difficile: Treating Sustained Antibiotic Responders With Fecal Microbiota Transplantation Does Not Improve EfficacySara Ellegaard Paaske, Simon Mark Dahl Baunwall, Gianluca Ianiro, et al.
Gut|November 26, 2025
Towards optimising and standardising donor screening for faecal microbiota transplantionCrystal S Liu, Blair Merrick, Zahra S Taboun, et al.
Inflammatory Bowel Diseases|May 8, 2026
Disease phenotype affects treatment of late-onset inflammatory bowel disease: Analysis of a large UK cohortPeter F G Foulser, Laura Martinez-Gili, Sharmili Balarajah, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
The American Journal of Gastroenterology|February 8, 2019
Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical TrialJessica R Allegretti, Zain Kassam, Madeline Carrellas, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2019
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volumeRobin D Abeles, Benjamin H Mullish, Roberta Forlano, et al.
Gastroenterology|July 21, 2018
Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal MicrobiotaJulie A K McDonald, Benjamin H Mullish, Alexandros Pechlivanis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2019
High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver DiseaseRoberta Forlano, Benjamin H Mullish, Nikolaos Giannakeas, et al.
Nutrients|December 23, 2022
Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in HumansJessica-Miranda Bustamante, Tyson Dawson, Caitlin Loeffler, et al.
Alimentary Pharmacology & Therapeutics|November 9, 2021
Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel diseaseShiva T Radhakrishnan, James L Alexander, Benjamin H Mullish, et al.
Gut Microbes|March 25, 2021
Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?Benjamin H Mullish, Julian R Marchesi, Julie A K McDonald, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2025
Clostridioides difficile: Treating Sustained Antibiotic Responders With Fecal Microbiota Transplantation Does Not Improve EfficacySara Ellegaard Paaske, Simon Mark Dahl Baunwall, Gianluca Ianiro, et al.
Gut|November 26, 2025
Towards optimising and standardising donor screening for faecal microbiota transplantionCrystal S Liu, Blair Merrick, Zahra S Taboun, et al.
Inflammatory Bowel Diseases|May 8, 2026
Disease phenotype affects treatment of late-onset inflammatory bowel disease: Analysis of a large UK cohortPeter F G Foulser, Laura Martinez-Gili, Sharmili Balarajah, et al.
Pageof 15